Zaid Haddadin1, Stockton Beveridge2, Kailee Fernandez1, Danielle A Rankin1,3, Varvara Probst1, Andrew J Spieker4, Tiffanie M Markus5, Laura S Stewart1, William Schaffner5,6, Mary Lou Lindegren1,5, Natasha Halasa1. 1. Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 2. Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA. 3. Vanderbilt Epidemiology PhD Program, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. 4. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 5. Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 6. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Abstract
BACKGROUND: Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections (ARIs) in hospitalized children. Although prematurity and underlying medical conditions are known risk factors, most of these children are healthy, and factors including RSV load and subgroups may contribute to severity. Therefore, we aimed to evaluate the role of RSV in ARI severity and determine factors associated with increased RSV-ARI severity in young children. METHODS: Children aged <5 years with fever and/or ARI symptoms were recruited from the emergency department (ED) or inpatient settings at Vanderbilt Children's Hospital. Nasal and/or throat swabs were tested using quantitative reverse-transcription polymerase chain reaction for common respiratory viruses, including RSV. A severity score was calculated for RSV-positive children. RESULTS: From November 2015 through July 2016, 898 participants were enrolled, and 681 (76%) had at least 1 virus detected, with 191 (28%) testing positive for RSV. RSV-positive children were more likely to be hospitalized, require intensive care unit admission, and receive oxygen compared with children positive for other viruses. Higher viral load, White race, younger age, and higher severity score were independently associated with hospitalization in RSV-positive children. No differences in disease severity were noted between RSV A and RSV B. CONCLUSIONS: RSV was associated with increased ARI severity in young children enrolled from the ED and inpatient settings, but no differences in disease severity were noted between RSV A and RSV B. These findings emphasize the need for antiviral therapy and/or preventive measures such as vaccines against RSV in young children.
BACKGROUND: Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections (ARIs) in hospitalized children. Although prematurity and underlying medical conditions are known risk factors, most of these children are healthy, and factors including RSV load and subgroups may contribute to severity. Therefore, we aimed to evaluate the role of RSV in ARI severity and determine factors associated with increased RSV-ARI severity in young children. METHODS: Children aged <5 years with fever and/or ARI symptoms were recruited from the emergency department (ED) or inpatient settings at Vanderbilt Children's Hospital. Nasal and/or throat swabs were tested using quantitative reverse-transcription polymerase chain reaction for common respiratory viruses, including RSV. A severity score was calculated for RSV-positive children. RESULTS: From November 2015 through July 2016, 898 participants were enrolled, and 681 (76%) had at least 1 virus detected, with 191 (28%) testing positive for RSV. RSV-positive children were more likely to be hospitalized, require intensive care unit admission, and receive oxygen compared with children positive for other viruses. Higher viral load, White race, younger age, and higher severity score were independently associated with hospitalization in RSV-positive children. No differences in disease severity were noted between RSV A and RSV B. CONCLUSIONS: RSV was associated with increased ARI severity in young children enrolled from the ED and inpatient settings, but no differences in disease severity were noted between RSV A and RSV B. These findings emphasize the need for antiviral therapy and/or preventive measures such as vaccines against RSV in young children.
Authors: Natasha B Halasa; John V Williams; Gregory J Wilson; William F Walsh; William Schaffner; Peter F Wright Journal: Pediatr Infect Dis J Date: 2005-12 Impact factor: 2.129
Authors: Rodica Gilca; Gaston De Serres; Mireille Tremblay; Marie-Louise Vachon; Eric Leblanc; Michel G Bergeron; Pierre Dery; Guy Boivin Journal: J Infect Dis Date: 2005-11-18 Impact factor: 5.226
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Chadi M El Saleeby; Andy J Bush; Lisa M Harrison; Jody A Aitken; John P Devincenzo Journal: J Infect Dis Date: 2011-10-01 Impact factor: 5.226
Authors: Ryan S Thwaites; Matthew Coates; Kazuhiro Ito; Marwa Ghazaly; Calandra Feather; Farhana Abdulla; Tanushree Tunstall; Pooja Jain; Lindsey Cass; Garth Rapeport; Trevor T Hansel; Simon Nadel; Peter Openshaw Journal: Am J Respir Crit Care Med Date: 2018-10-15 Impact factor: 21.405
Authors: Caroline Breese Hall; Geoffrey A Weinberg; Aaron K Blumkin; Kathryn M Edwards; Mary A Staat; Andrew F Schultz; Katherine A Poehling; Peter G Szilagyi; Marie R Griffin; John V Williams; Yuwei Zhu; Carlos G Grijalva; Mila M Prill; Marika K Iwane Journal: Pediatrics Date: 2013-07-22 Impact factor: 7.124
Authors: James A Fuller; M Kariuki Njenga; Godfrey Bigogo; Barrack Aura; Maurice O Ope; Leonard Nderitu; Lilian Wakhule; Dean D Erdman; Robert F Breiman; Daniel R Feikin Journal: J Med Virol Date: 2013-05 Impact factor: 2.327
Authors: Zaid Haddadin; Jennifer E Schuster; Andrew J Spieker; Herdi Rahman; Anna Blozinski; Laura Stewart; Angela P Campbell; Joana Y Lively; Marian G Michaels; John V Williams; Julie A Boom; Leila C Sahni; Mary Staat; Monica McNeal; Rangaraj Selvarangan; Christopher J Harrison; Geoffrey A Weinberg; Peter G Szilagyi; Janet A Englund; Eileen J Klein; Aaron T Curns; Brian Rha; Gayle E Langley; Aron J Hall; Manish M Patel; Natasha B Halasa Journal: Pediatrics Date: 2021-05-13 Impact factor: 7.124
Authors: Danielle A Rankin; Zaid Haddadin; Loren Lipworth; Anna L Stahl; Jon Fryzek; Mina Suh; Donald S Shepard; Rebekkah Varjabedian; Kailee N Fernandez; Seifein Salib; Jessica Villarreal; Mercedes Bruce; Rendie McHenry; Andrew J Spieker; Christopher B Nelson; Natasha B Halasa Journal: Ther Adv Infect Dis Date: 2022-07-18
Authors: Katrin Hartmann; Johannes G Liese; Daniel Kemmling; Christiane Prifert; Benedikt Weißbrich; Pushpike Thilakarathne; Joris Diels; Karin Weber; Andrea Streng Journal: J Infect Dis Date: 2022-08-26 Impact factor: 7.759
Authors: Clarissa M Koch; Andrew D Prigge; Leah Setar; Kishore R Anekalla; Hahn Chi Do-Umehara; Hiam Abdala-Valencia; Yuliya Politanska; Avani Shukla; Jairo Chavez; Grant R Hahn; Bria M Coates Journal: Front Immunol Date: 2022-09-23 Impact factor: 8.786